Triple-Receptor Activity
Studied for concurrent activity at GLP-1, GIP, and glucagon receptors.

Retatrutide research pen supplied for controlled laboratory research use only. Not for human or animal consumption.

A triple-receptor agonist investigated across GLP-1, GIP, and glucagon pathways in metabolic, appetite, and body-composition research.
A triple-receptor agonist investigated across GLP-1, GIP, and glucagon pathways in metabolic, appetite, and body-composition research.

A simplified overview of the compound-specific research pathways associated with Retatrutide Pen 20mg.
Studied for concurrent activity at GLP-1, GIP, and glucagon receptors.
Research examines satiety and food-intake signalling.
Studies investigate glucose, lipid, and energy-balance pathways.
Research evaluates changes in weight and body-composition markers.
Clear answers for researchers before you order.

A triple-receptor agonist investigated across GLP-1, GIP, and glucagon pathways in metabolic, appetite, and body-composition research.
This product is supplied as a lyophilized powder in a sealed research vial.
Yes. Batches are verified for identity, purity, and research-grade quality standards.
Products are supplied to a 99%+ purity standard where stated on the product specification.
Store at 2–8°C and keep sealed, protected, and handled according to appropriate research-lab protocols.
Yes. Lab report information is available with every batch where applicable.
No. This product is supplied for research use only and is not for human consumption.
| Retatrutide | 20.64 mg |
| Purity | 99.265% |
6N8BEI6MKCRK